Quality from Austria
The sustainable choice
SUSTAINABILITY MEANS
SECURITY OF SUPPLY
More than just the environment –
Responsibility for healthcare
Sustainability is often reduced to the carbon footprint. For healthcare systems, however, this is only part of the picture. It means ensuring the long-term care of patients, making healthcare systems more resilient, and taking responsibility throughout the entire life cycle of a medicine – from development and production to reliable supply.
TOGETHER FOR A BRIGHTER LIFE
Healthcare systems need resilient partners
Hospitals and healthcare systems today face a twofold challenge: they must ensure the highest standards of medical care whilst at the same time safeguarding their long-term provision of care. They need partners they can rely on. Resilient supply chains, regulatory certainty and swift decision-making processes are now key prerequisites for patient care.
“Choosing a contrast agent also means opting for regional production and a reliable long-term supply.”
Kerstin Schanda, Sanochemia
OUR CONTRIBUTION
Taking
responsibility
together
In the debate surrounding contrast agents, sustainability is often reduced to individual product characteristics. In MRI, the focus is particularly on using less gadolinium. While this approach is understandable, it doesn’t go far enough. The decision on which contrast agent to use extends far beyond the product itself. It also affects security of supply, supply chains, regional value creation, and the long-term stability of healthcare systems.
It is important to consider the system as a whole. Choosing a contrast agent is, at the same time, a decision about the kind of healthcare system we wish to strengthen in the long term. Development and production in Austria not only result in high-quality medicines but also create long-term added value for the country: jobs, regulatory expertise and pharmaceutical know-how remain in Austria, whilst short transport routes simultaneously contribute to a lower environmental impact.
>35
years
Decades of experience
Over 35 years’ expertise in the manufacture of contrast agents. With an annual production capacity of around 5 million bottles, our products enable around 30,000 CT and MRI scans to be carried out every day worldwide.
EU
based
Austrian production
Development and production at our Austrian site combine pharmaceutical expertise with the highest quality standards and reliable delivery capabilities.
>50
countries
Global presence
Our products are supplied to healthcare systems in over 50 countries. We combine international experience with personalised support and a reliable supply.
Fe –
Iron
Diagnostic innovation
We are constantly evaluating new MRI contrast agents in order to broaden the range of options available for different clinical issues and patient groups, and to open up new perspectives in imaging.